Maggie Hassan. The setup forced many users to pay higher prices and allowed the British drugmaker to avoid paying Medicaid ...
GSK is sourcing early-stage science across a wide range of technologies and disease areas, while placing more selective bets ...
After GSK replaced a popular asthma inhaler with an identical product at a higher price, families reported substantial ...
Zacks Investment Research on MSN
GSK's Risvutatug Rezetecan gets Japan orphan drug tag for lung cancer
GSK plc GSK announced that Japan’s Ministry of Health, Labour and Welfare has granted Orphan Drug Designation (ODD) to ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — A blood cancer treatment from GSK helped patients live longer in ...
Friday, GSK plc (NYSE:GSK) released the headline results of the MATINEE Phase 3 trial evaluating Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5 (IL-5) in adults with chronic ...
BLENREP is a first-in-class anti-BCMA (B-cell maturation antigen) therapy for patients whose disease has progressed despite prior treatment with an immunomodulatory agent, proteasome inhibitor and ...
GSK’s Lynavoy receives US FDA approval for cholestatic pruritus in patients with primary biliary cholangitis: London, UK Saturday, March 21, 2026, 11:00 Hrs [IST] GSK plc announ ...
With its significant population, skilled talent, and a government deeply committed to health, the country presents a unique ...
There is a significant gap in patients’ understanding of treatment options for gynecologic cancers, according to a survey conducted by The Harris Poll on behalf of GSK. In a poll of more than 800 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results